134099-30-2

Basic information

• Product Name: alpha,alpha,alpha,2,4-Pentafluoro-m-tolualdehyde, 2,6-Difluoro-3-formylbenzotrifluoride
• Synonyms: 2,4-Difluoro-3-(trifluoromethyl)benzaldehyde 98%;alpha,alpha,alpha,2,4-Pentafluoro-m-tolualdehyde, 2,6-Difluoro-3-formylbenzotrifluoride;2,4-Difluoro-3-(trifluoromethyl)benzaldehyde98%
• CAS NO: 134099-30-2
• Molecular Weight: 210.103
• Mol File: 134099-30-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: alpha,alpha,alpha,2,4-Pentafluoro-m-tolualdehyde, 2,6-Difluoro-3-formylbenzotrifluoride(CAS DataBase Reference)
• NIST Chemistry Reference: alpha,alpha,alpha,2,4-Pentafluoro-m-tolualdehyde, 2,6-Difluoro-3-formylbenzotrifluoride(134099-30-2)
• EPA Substance Registry System: alpha,alpha,alpha,2,4-Pentafluoro-m-tolualdehyde, 2,6-Difluoro-3-formylbenzotrifluoride(134099-30-2)

Safety Data

• Hazardous Substances Data: 134099-30-2(Hazardous Substances Data)

Upstream product

• 64248-60-8 1,3-difluoro-2-(trifluoromethyl)benzene 
• 68-12-2 N,N-dimethyl-formamide 

Relevant articles and documents

GEMINAL SUBSTITUTED QUINUCLIDINE AMIDE COMPOUNDS AS AGONISTS OF ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTORS

The present invention relates to novel geminal substituted quinuclidine amide compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial agonists of α7- nAChR, and methods of preparing these compounds and compositions, and the use of these compounds and compositions in methods of maintaining, treating and/or improving cognitive function. In particular, methods of administering the compound or composition to a patient in need thereof, for example a patient with a cognitive deficiency and/or a desire to enhance cognitive function, that may derive a benefit therefrom.